These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 391462)

  • 1. Hepatic first-pass metabolism in liver disease.
    Blaschke TF; Rubin PC
    Clin Pharmacokinet; 1979; 4(6):423-32. PubMed ID: 391462
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.
    Gilmore IT; Hofmann AF
    Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug administration in hepatic disease.
    Williams RL
    N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic clearance measurements and pharmacokinetics.
    Keiding S; Andreasen PB
    Pharmacology; 1979; 19(3):105-10. PubMed ID: 392549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
    Danysz A
    Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug pharmacokinetics in cardiac and hepatic disease.
    Williams RL; Benet LZ
    Annu Rev Pharmacol Toxicol; 1980; 20():389-413. PubMed ID: 6992701
    [No Abstract]   [Full Text] [Related]  

  • 8. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-pass metabolism.
    Brodie MJ
    Practitioner; 1983 Oct; 227(1384):1619-27. PubMed ID: 6634632
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacokinetics.
    Atkinson AJ; Kushner W
    Annu Rev Pharmacol Toxicol; 1979; 19():105-27. PubMed ID: 378099
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug kinetics and hepatic blood flow.
    George CF
    Clin Pharmacokinet; 1979; 4(6):433-48. PubMed ID: 391463
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug metabolism in liver diseases].
    Paumgartner G
    Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370
    [No Abstract]   [Full Text] [Related]  

  • 13. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of various physiological and pathological conditions on the bioavailability of drugs].
    Danysz A; Wierzba K
    Pol Tyg Lek; 1979 Jan; 34(4):141-3. PubMed ID: 432125
    [No Abstract]   [Full Text] [Related]  

  • 15. [Side effects of drugs--predictable hazards for patients with liver disease].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of liver disease on drug disposition in man.
    Wilkinson GR; Schenker S
    Biochem Pharmacol; 1976 Dec; 25(24):2675-81. PubMed ID: 795432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heterogenicity of liver parenchyma cells].
    Van Steenbergen W
    Acta Clin Belg; 1985; 40(6):376-87. PubMed ID: 3913260
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug metabolism and liver disease in India.
    Narang AP; Kaur U; Bambery P
    Drug Metab Rev; 1991; 23(1-2):65-81. PubMed ID: 1868778
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.